Jan 19, 2021

Research establishes antibiotic potential for cannabis molecule

Posted by in category: biotech/medical

Synthetic cannabidiol, better known as CBD, has been shown for the first time to kill the bacteria responsible for gonorrhea, meningitis and legionnaires disease.

The between The University of Queensland and Botanix Pharmaceuticals Limited could lead to the first new class of for in 60 years.

The UQ Institute for Molecular Bioscience’s Associate Professor Mark Blaskovich said CBD—the main nonpsychoactive component of cannabis—can penetrate and kill a wide range of bacteria including Neisseria gonorrhoeae, which causes gonorrhea.

Leave a reply